Cargando…

Copper and zinc isotopic excursions in the human brain affected by Alzheimer's disease

INTRODUCTION: Alzheimer's disease (AD) is neuropathologically marked by amyloid beta (Aβ) plaques and neurofibrillary tangles. Little is known about isotopic compositions of human AD brains. Here we study this in comparison with control subjects for copper and zinc. METHODS: We use mass‐spectro...

Descripción completa

Detalles Bibliográficos
Autores principales: Moynier, Frédéric, Borgne, Marie Le, Lahoud, Esther, Mahan, Brandon, Mouton‐Liger, Francois, Hugon, Jacques, Paquet, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571480/
https://www.ncbi.nlm.nih.gov/pubmed/33102682
http://dx.doi.org/10.1002/dad2.12112
_version_ 1783597179414249472
author Moynier, Frédéric
Borgne, Marie Le
Lahoud, Esther
Mahan, Brandon
Mouton‐Liger, Francois
Hugon, Jacques
Paquet, Claire
author_facet Moynier, Frédéric
Borgne, Marie Le
Lahoud, Esther
Mahan, Brandon
Mouton‐Liger, Francois
Hugon, Jacques
Paquet, Claire
author_sort Moynier, Frédéric
collection PubMed
description INTRODUCTION: Alzheimer's disease (AD) is neuropathologically marked by amyloid beta (Aβ) plaques and neurofibrillary tangles. Little is known about isotopic compositions of human AD brains. Here we study this in comparison with control subjects for copper and zinc. METHODS: We use mass‐spectrometry methods, developed to study extraterrestrial materials, to compare the copper and zinc isotopic composition of 10 AD and 10 control brains. RESULTS: Copper and zinc natural isotopic compositions of AD brains are statistically different compared to controls, and correlate with Braak stages. DISCUSSION: The distribution of natural copper and zinc isotopes in AD is not affected by the diet, but is a consequence of Aβ plaques and tau fibril accumulation. This is well predicted by the changes of the chemical bonding environment caused by the development of Aβ lesions and accumulation of tau proteins. Future work will involve testing whether these changes affect brain functions and are propagated to body fluids.
format Online
Article
Text
id pubmed-7571480
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-75714802020-10-23 Copper and zinc isotopic excursions in the human brain affected by Alzheimer's disease Moynier, Frédéric Borgne, Marie Le Lahoud, Esther Mahan, Brandon Mouton‐Liger, Francois Hugon, Jacques Paquet, Claire Alzheimers Dement (Amst) Diagnostic Assessment & Prognosis INTRODUCTION: Alzheimer's disease (AD) is neuropathologically marked by amyloid beta (Aβ) plaques and neurofibrillary tangles. Little is known about isotopic compositions of human AD brains. Here we study this in comparison with control subjects for copper and zinc. METHODS: We use mass‐spectrometry methods, developed to study extraterrestrial materials, to compare the copper and zinc isotopic composition of 10 AD and 10 control brains. RESULTS: Copper and zinc natural isotopic compositions of AD brains are statistically different compared to controls, and correlate with Braak stages. DISCUSSION: The distribution of natural copper and zinc isotopes in AD is not affected by the diet, but is a consequence of Aβ plaques and tau fibril accumulation. This is well predicted by the changes of the chemical bonding environment caused by the development of Aβ lesions and accumulation of tau proteins. Future work will involve testing whether these changes affect brain functions and are propagated to body fluids. John Wiley and Sons Inc. 2020-10-19 /pmc/articles/PMC7571480/ /pubmed/33102682 http://dx.doi.org/10.1002/dad2.12112 Text en © 2020 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, LLC on behalf of Alzheimer's Association https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Diagnostic Assessment & Prognosis
Moynier, Frédéric
Borgne, Marie Le
Lahoud, Esther
Mahan, Brandon
Mouton‐Liger, Francois
Hugon, Jacques
Paquet, Claire
Copper and zinc isotopic excursions in the human brain affected by Alzheimer's disease
title Copper and zinc isotopic excursions in the human brain affected by Alzheimer's disease
title_full Copper and zinc isotopic excursions in the human brain affected by Alzheimer's disease
title_fullStr Copper and zinc isotopic excursions in the human brain affected by Alzheimer's disease
title_full_unstemmed Copper and zinc isotopic excursions in the human brain affected by Alzheimer's disease
title_short Copper and zinc isotopic excursions in the human brain affected by Alzheimer's disease
title_sort copper and zinc isotopic excursions in the human brain affected by alzheimer's disease
topic Diagnostic Assessment & Prognosis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571480/
https://www.ncbi.nlm.nih.gov/pubmed/33102682
http://dx.doi.org/10.1002/dad2.12112
work_keys_str_mv AT moynierfrederic copperandzincisotopicexcursionsinthehumanbrainaffectedbyalzheimersdisease
AT borgnemariele copperandzincisotopicexcursionsinthehumanbrainaffectedbyalzheimersdisease
AT lahoudesther copperandzincisotopicexcursionsinthehumanbrainaffectedbyalzheimersdisease
AT mahanbrandon copperandzincisotopicexcursionsinthehumanbrainaffectedbyalzheimersdisease
AT moutonligerfrancois copperandzincisotopicexcursionsinthehumanbrainaffectedbyalzheimersdisease
AT hugonjacques copperandzincisotopicexcursionsinthehumanbrainaffectedbyalzheimersdisease
AT paquetclaire copperandzincisotopicexcursionsinthehumanbrainaffectedbyalzheimersdisease